On Wednesday, Whiting Petroleum Corp (NYSE:WLL)’s shares declined -5.37% to $8.64. The market capitalization of Whiting Petroleum Corp (NYSE:WLL) is $1.86 billion with the total traded volume of the company is 12.18 million. Turning to market valuation, the Price-to-Sales ratio is 0.75 and the Price-to-Book ratio is finally 0.36. The beta ratio has a value of 2.18.
Whiting Petroleum Corporation, an independent oil and gas company, acquires, explores, develops, and produces crude oil, natural gas liquids, and natural gas in the Rocky Mountains and Permian Basin regions of the United States. It sells oil and gas to end users, marketers, and other purchasers.
Schlumberger Limited. (NYSE:SLB)’s shares dropped -1.25% to $69.63. The last trading range of Schlumberger Limited. (NYSE:SLB) ranges between $69.38 and $70.53. The EPS of the company stands at $2.66. The 52-week range shows that the stock reached higher at $95.13 while its lower range is $66.57 in the last 52-weeks. The average volume of the company is at 7.84 million with the Outstanding Shares of 1.26 billion. The market capitalization of the company is $88.71 billion. The Beta of the company stands at 1.58 with the RSI (Relative Strength Index) of 40.13.
Schlumberger Limited supplies technology, integrated project administration, and information solutions to the oil and gas exploration and production industries worldwide. The company operates through Reservoir Characterization Group, Drilling Group, and Production Group segments.
Allergan plc Ordinary Shares (NYSE:AGN)‘s shares surged 0.09% to $315.06. Allergan plc Ordinary Shares (NYSE:AGN) is now worth about $123.98 billion. The share price has made a 2.77% gain in the past 5 days and has gained 22.4% since 2015 kicked off. Analysts are forecasting EPS growth of -6.77% for next fiscal year and 9.00% growth in the next 5 years. The stock trades with a beta of 0.68. The stock price is above by 4.56% as contrast to the average price over the last 200 days. The company has 63.00% gross margins.
Allergan plc develops, manufactures, and distributes generic, branded, biosimilar, and over-the-counter (OTC) pharmaceutical products. It operates in three segments: North American Brands, North American Generics and International, and Anda Distribution. The North American Brands segment provides patented and off-patent trademarked pharmaceutical products primarily under the Dalvance, Bystolic, Canasa, Carafate, Daliresp, Fetzima, Linzess, Namenda, Namenda XR, Saphris, Teflaro, Viibryd, Actonel, Asacol HD, Atelvia, Delzicol, Doryx, Estrace Cream, Enablex, Lo Loestrin Fe, and Minastrin 24 Fe brands.
